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ABSTRACT 
 
Oxidative stress is an imbalance between reactive oxygen species(ROS) production and antioxidant defense system 
and considered to be involved in the etiology of various type of diseases including cancers. Although, since last many 
decades several antioxidants belonging to the various synthetic and natural classes and plant extracts have been tested 
in clinical trials against oxidative stress induced various diseases however, these clinical trials end with antioxidants 
undesirable effects. In this review, we will describe the most recent findings in the oxidative stress field, highlighting 
sources of free radical’s production and its related oxidative damage at cellular and molecular level, we will also have 
described new and existing classes of antioxidants and free radical scavengers and their related clinical trials. 
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1. Free Radicals and Oxidative Damage: 
Chemistry, Cell and Molecular Biology 
 
Atoms, molecules or ions with outer shell unpaired electron are 
called free radicals. Unpaired electrons are capable of altering 
an atom’s or a molecule’s chemical reactivity, thereby making 
it more reactive towards other molecules (Lü, Lin, Yao, and 
Chen, 2010). In biological systems, these free radicals 
originate from oxygen, nitrogen, and sulphur during a number 
of biochemical processes, and in normal and abnormal cell 
metabolism (Sies, 2018). All these free radicals inside the cells 
form a group of molecules called reactive 
oxygen/nitrogen/sulfur species (ROS/RNS/RSS). One of the 
important groups of free radicals is reactive oxygen species 
(ROS) that induces transformation of superoxide anion (O2
‾•), 
hydroperoxyl radical (HO2), hydrogen peroxide (H2O2), singlet 
oxygen (1O2), and hydroxyl radical (OH•‾) (Carocho and 
Ferreira, 2013).   Mitochondrial electron transport chain (ETC) 
is the main source of superoxide anion. However, free radicals 
are also produced by peroxisomes, and during the process 
catalyzed by enzymes, such as xanthine oxidase, and NADPH 
oxidase. 
 
However, several cell metabolic and physiological processes, 
such as phagocytosis, inflammation, and physical exercise also 
initiate free radical production (Gào and Schöttker, 2017). 
Mitochondrial complex I, complex II, and complex III that 
reside at the inner mitochondrial membrane can leak electrons 
that react with molecular oxygen, and start ROS production by 
generating superoxide (Loschen et al., 1974; Sabharwal and 
Schumacker, 2014; Simula, Nazio, and Campello, 2017). 
 
Superoxide stays in the compartment where it is generated due 
to its low membrane permeability. However, despite the low 
membrane permeability, small amounts of superoxide, and 
hydrogen peroxide can diffuse from the mitochondria via 
voltage dependent anion channel (VDAC), and oxidize one or 
more cysteine residues; hence, altering protein structure and 
activity (Belhadj Slimen et al., 2014). Various physiological 
processes are controlled by redox regulation (Bak and 
Weerapana, 2015). The reactions leading to the production of 
ROS are shown in Fig. 1.1.  
 
Superoxide anion is generated either through enzymes or 
metal-catalyzed processes. Superoxide dismutase (SOD) can 
dismutate the superoxide to hydrogen peroxide, while catalase 
(CAT) will reduce hydrogen peroxide to water. The Fenton 
reaction transforms hydrogen peroxide to the hydroxyl radical 
HO• in the presence of iron (Carocho and Ferreira, 2013). In 
cellular and biological systems, superoxide-driven Fenton and 
Haber–Weiss reactions play important roles as they generate 
highly reactive radicals from the poorly reactive ones. ROS, 
especially hydroxyl radicals, are capble of attacking all 
biomolecules, thus producing damage, and contributing to the 
endothelial dysfunction, which is a starting point for cancers. 
Iron (Fe2+) may be a possible reason for the formation of ROS, 
but its importance in this process is still questionable 
(Formanowicz, Radom, Rybarczyk, and Formanowicz, 2018). 
A reactive nitrogen species (RNS), peroxynitrite (ONOO−), is 
formed when the second messenger, nitric oxide (•NO) free 
radical, is  
O2 + e- + H+   
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Fig. 1.1: Overview of ROS production in human cellular systems. Green arrow shows lipid peroxidation. Haber–Weiss reactions and 
the Fenton reactions are indicated by blue and red arrows, respectively. Radicals or reactive molecules (H2O2) are indicated by bold 
letters. Enzyme catalase and superoxide dismutase are shortened as SOD and CAT, respectively (Carocho and Ferreira, 2013). 
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produced endogenously by nitric oxide synthases,which 
reacts with superoxide (O2•‾), the resulting ONOO‾ further 
reacts with other chemical entities and form dinitrogen 
trioxide (N2O3) and nitrogen dioxide (
•NO2). Among all the 
RNS, only (ONOO‾) is highly reactive, and potentially cause 
damage to macromolecules, since it can enter through anion 
channels inside the cell where it reacts slowly and selectively 
with the biological macromolecules throughout the cells, 
including protein thiol groups, amino acid residues, lipids, 
and DNA bases (Cortese-Krott et al., 2017). Similar to ROS 
and RNS, RSS originate from thiols and form a disulfide, 
either disulfide-S-monoxide or disulfide-S-dioxide as a result 
of further oxidation (Giles and Jacob, 2002; Olson et al., 
2018). In biological system, RSS, ROS, and RNS also act as 
signaling molecules. 
 
2. Molecular Targets and Mechanism of Free 
Radical Damage 
 
Free radicals can react and oxidize all major biological 
macromolecules in the cells, including deoxyribonucleic 
acid (DNA), ribonucleic acid (RNA), sugars, lipids, and 
proteins (Lü, Lin, Yao, and Chen, 2010; Matkarimov and 
Saparbaev, 2017) (Fig. 1.2). Proteins undergo three distinct 
types of oxidative modifications: (1) cysteine residues of 
signaling proteins can 
 
be modified to disulfide or to sulfenic acids or to carbonyl 
derivatives, (2) free radical induced peptide bond cleavage, and 
(3) cross-linked protein production due to the reaction of protein 
with lipid peroxidation products (Lobo et al., 2010) (Fig. 1.2). The 
protein oxidation consequentely effects changes in structures and 
functions of proteins. Hydroxyl radicals can extract a hydrogen 
atom from methylene carbon of a fatty acid and thereby initiate 
lipid peroxidation. The lipid radical can undergo molecular 
rearrangement, and react with oxygen to produce a peroxyl 
radical. Peroxyl radicals can propagate a chain reaction to form 
trichloromethyl radical (CCl3O2) after addition of oxygen to 
carbon tetrachloride (CCl4) that can attack the lipids (Gaschler 
and Stockwell, 2017) (Fig. 1.2). 
 
Polyunsaturated fatty acids (PUFAs) are more prone to free 
radical attack due to their large number of double bonds as 
compared to monounsaturated (MUFA) and saturated fatty acids 
(SFA). A minor pathway of lipid peroxidation initiates when 
singlet oxygen generates lipid peroxides by attacking PUFA’s 
side chains. The end products of lipid peroxidation affect signal 
transduction as second messengers, and also exert cytotoxic or 
genotoxic effects (Agmon and Stockwell, 2017; Zielinski and 
Pratt, 2017) (Fig. 1.2). 
 
 
 
 
 
Free 
Radicals
 
 
Fig. 1.2: Molecular targets of free radicals.  
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 Oxidative damage to DNA includes both chemical and 
structural changes induced by free radicals. These chemical 
and structural changes result in characteristic modifications, 
including strand breaks, base free sites, deletions, base 
modification, frame shifts, chromosomal rearrangement, and 
DNA protein cross-links (Fig. 1.2). Hydroxyl radicals can 
oxidize all components of the DNA molecule, including 
deoxyribose backbone, and purine and pyrimidine bases. 
Peroxyl radical also participates in DNA oxidation 
(Dizdaroglu, Jaruga, Birincioglu, and Rodriguez 2002; Valko, 
et al., 2004; Chen et al., 2014). ROS induced oxidative damage 
to DNA triggers a response to recover DNA damage, and limit 
mutagenesis, cytostasis, and cytotoxicity (McAdam, Brem, and 
Karran, 2016). Free radicals formed during non-enzymatic 
glycation result in glycoxidative damage (Fig. 1.2). During 
glycation, superoxide radicals are produced by autoxidation of 
short chain molecules, such as glycoaldehyde. Well known 
mutagens such as ß-dicarbonyls are formed from 
glycoaldehyde radical by propagation of further chain reaction 
(Ahmad et al., 2017).  
 
ROS relay cellular signals in a number of cell events by acting 
as second messengers. However, in bio-molecules, ROS can 
also induce reversible structural modifications (Li, Jia, and 
Trush, 2016) that modulate cellular processes. There are 
several ROS specific signal transduction pathways reported in 
literature, such as stress-activated/ c-Jun N-terminal protein 
kinase, NF-KB, AP-1, mitogen and stress-activated kinases 
(MSK), and p38 group of protein kinases (Marengo et al., 
2016). 
 
ROS can also act as physiological mediators in cellular 
processes in addition to exerting its harmful effects. The redox 
homeostasis is a balanced state of cellular ROS concentrations 
(Ursini, Maiorino, and Forman, 2016) achieved by fine tuning 
of ROS production and ROS detoxifications via specific 
cellular system like NADPH oxidases, and intracellular 
antioxidant defense system, including thioredoxin, catalase 
glutathione peroxidase or superoxide dismutases (Hawk and 
Schafer, 2018). 
During different physiological cellular events, such as 
apoptosis, autophagy, and cell adhesion, the redox status of 
cells may encounter temporary or stable changes, depending 
upon the events that take place in a cell. If the redox status of 
the cell is unbalanced, the cells begin to suffer when ROS 
production is augmented or/and ROS detoxification is 
decreased (Sies, 2015). 
In addition to a number of diseases, oxidative damage is also 
believed to contribute to the onset of various types of cancers 
(Rahman, 2007; Lobo et al., 2010; Rani et al., 2016). However, 
it is not known if excess oxidation is a source or result of these 
diseases.  
Due to this reason, oxidative stress can either be a cause or a 
consequence of some diseases, including various types of 
cancers,  
neurological disorders (Autism, Alzheimer’s, Parkinson’s, and 
Huntington’s diseases), trauma, cardiovascular diseases 
(atherosclerosis, hypertension, and stroke), renal disorders 
(glomerulonephritis), liver disorders (Alcoholic liver disease), 
adult respiratory distress syndrome, auto-immune diseases 
(lupus erythematous, and rheumatoid arthritis), inflammation, 
diabetes mellitus, diabetic complications, cataracts, obesity, 
vasculitis, gastric ulcers, hemochromatosis, and preeclampsia, 
among others (Rahman, 2007; Lobo, Patil, Phatak, and 
Chandra, 2010; Rani et al., 2016). As a consequence, new area 
of research has emerged to understand the antioxidant effects 
of potential drug candidates. 
 
3. Antioxidants and Free Radical Scavengers 
 
Antioxidants are substances of natural or synthetic source that 
may prevent the process of oxidation of macromolecules by 
scavenging free radicals. It has also been suggested that they 
may act by stimulating the expression of free radical quenching 
enzymes, or by inhibition of free radical producing enzymes 
(Forman, Davies, and Ursini, 2014). Free radical scavengers 
may provide new therapeutic strategies for oxidative stress-
related diseases. A variety of plant-based free radical 
scavengers has been described in the literature that are claimed 
to exert their beneficial effects against free radical induced 
damage in biological system; some of them are currently used 
for therapeutic purposes (Dodd et al., 2008). Various fully 
characterized natural product based antioxidants have been 
identified; among them are carotenes, estrogens, melatonin, 
ascorbic acid, tocopherols, uric acid, tocotrienols, glutathione, 
ubiquinol, bilirubin, lipoic acid, polyphenols, etc. (Singh, 
Kesharwani, and Keservani, 2018). Apart from the natural 
ones, numerous non-natural free radical scavengers have been 
synthesized from previously existing natural templates. They 
are being tested in cellular and molecular models of oxidative 
stress for their efficacy (Qurat-ul-Ain, Choudhary, and 
Scharffetter-Kochanek, 2017). 
 
3.1. Pyrimidine Derivatives 
 
Pyrimidine nucleotide bases are building block of DNA and 
RNA, and synthetic pyrimidine derivatives exhibit a large 
number of biological activities (Geng et al., 2018). The 
pyrimidine analogues decorated with radical scavenging 
functionalities have been found to counteract oxidative stress 
induced cancers in many in vitro and in vivo systems, either by 
intercalating with DNA nucleotide bases or by reducing free 
radical induced DNA mutations with subsequent cancer cell 
growth retardation (Sankarganesh et al., 2017). Many anti-
cancer and anti-viral therapies work primarily by these 
mechanisms (Fig. 1.3) (Ashid et al., 2016; Kaur et al., 2015).  
 
In recent years, anti-cancer drugs are often based on 
pyrimidine analogues that are either in clinical practice or 
being evaluated in clinical studies (Cawrse et al., 2018).  
 
5 
 
  
                                       
    
              
Zidovudine (ZDV)                                                   Fluorouracil (5-FU) 
 
 
Fig. 1.3: Structures of pyrimidine based drugs. Zidovudine is clinically used anti-viral drug, and fluorourical clinically available and 
orally active anti-cancer agent based on pyrimidine moiety Ashid et al., 2016), structure (1) represents newly identified free radical 
scavenger with anti-proliferation activities (Qurat-ul-Ain et al., 2017). 
 
These compounds are based on a benzene ring joined to a pyrone 
ring. Their diverse pharmacological properties have attracted 
immense scientific interest in recent years (Fig. 1.4) (Stefanachi, 
2018). Coumarin derivatives are now the subject of intensive 
research due to their biological activities (Detsi, Kontogiorgis, 
and Hadjipavlou-Litina, 2017). Recently, in in vivo models 
coumarins have exhibited anti-hepatotoxic activity. They were 
also found to deplete cytochrome P450 (Singh and Pathak, 2016).  
Furthermore, a 6-functionalized 1-azacoumarin is an orally active 
anti-tumor drug, and has recently been tested in human clinical 
trials 
 
Identification of antioxidant molecules with DNA binding 
activities, and investigation of their molecular mechanisms of 
action towards oxidative damage induced diseases, such as 
some cancers, can offer new anti-cancer drug candidates (Bano, 
Kumar, and Dudhe, 2012; Barakat, et al., 2016). 
 
3.2. Bis-coumarin Derivatives 
 
Bis-coumarins are derived from the benzopyrone family of 
natural compounds.  
 
                                                                                                          
                                   
     Coumarin (1, 2-benzopyrone)                       7-Hydroxycoumarin 
 
 
Fig. 1.4: Structures of coumarin based anti-metastatic/anti-melanoma agents. Promising anti-metastatic/anti-melanoma agents: 
Coumarin (1,2-benzopyrone) and 7-Hydroxycoumarin are based on coumarin scaffold, and have been evaluated in phase II studies 
(Marshall et al., 1994; Mohler et al., 1992), compound (2) has been evaluated in oxidative stress cell models (Qurat-ul-Ain et al., 2018). 
 
 
 (2) 
                 
 (1) 
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trials in view of its capacity of inhibiting farnesylation in 
nanomolar concentrations. Due to adverse side effects associated 
with existing coumarins, there is still a need to synthesize and 
develop better inhibitors with an improved therapeutic index 
(Stefanchi et al., 2018).  
 
In various human cancer cell lines, such as HL-60 (leukemia), 
ACHN (renal), MCF-7 (breast), H727 (lung), and A549 (lung), 
coumarin and 7-hydroxycoumarin demonstrated growth-inhibitory 
cytostatic activity. They also have been evaluated in phase II 
clinical trials against prostate cancer, malignant melanoma, and 
metastatic renal cell carcinoma (Musa, et al., 2008). For example, 
coumarins with phenolic hydroxyl groups prevent the formation of 
5-hydroxyeicosatetraenoic acid (5-HETE) and 
hydroxyheptadecanoic acid (HHT) in the arachidonic 
inflammation pathway due to their ability to scavenge reactive 
oxygen species (Schneider and Bucar 2005).  
 
3.3. Thiazole Derivatives 
 
Thiazoles are aromatic compounds with five-membered 
heterocyclic ring. Due to their antioxidant, anti-convulsant, 
anti-inflammatory, anti-tumor, anti-hyperlipidemic, anti-
hypertensive, insecticidal, and pesticidal activities, thiazole 
compounds and their synthetic derivatives are used as active 
ingredients in various pharmaceutical formulations (Khan et al., 
2016; Salar et al., 2016).  
 
A clinically available anti-diabetic agent, Zopolrestat that is 
built upon thiazole moiety as its active ingredient, is effectively 
used against diabetic complications. Similarly, a modified 
thiazole benzene sulfonamides, i.e., N-(6-substituted-1, 3-
benzothiazol-2-yl) has been found to exhibit its potential as 
antidiabetic agent in in vivo system against NIDDM (non-
insulindependent diabetes mellitus) in an animal model (Fig. 
1.5) (Moreno-Díaz et al., 2008). 
 
     
 
 
 
 
Zopolrestat                                              
 
Benzene sulfonamides 
 
 
 (3) 
Fig. 1.5: Structures of clinically available drugs based on thiazole moiety. Zopolrestat and benzene sulfonamide N-(6-substituted-1,3-
benzothiazol-2-yl) have been synthesized based on thiazole moiety. Zopolrestat is a clinically available anti-diabetic agent while benzene 
sulfonamides N-(6-substituted-1,3-benzothiazol-2-yl) has been evaluated in preclinical trials as an anti-diabetic agent against NIDDM 
(Moreno-Díaz et al., 2008), compound (3) has been evaluated in oxidative stress cell models (Qurat-ul-Ain et al., 2017). 
 
 
3.4. Aryl Schiff’s Bases 
 
These synthetic compounds contain characteristic –HC=N– group 
Aryl Schiff’s bases were found to exhibit anti-pyretic, anti-fungal, 
anti-viral, anti-parasitic, anti-bacterial, anti-tubercular, anti-
inflammatory, and plant hormone activities. They also act as HDM2-
p53 protein-protein, and dual AKT1/2 inhibitors. They display P2X7, 
MCH1, and NPY5 antagonism (Parcha and Kaur, 2017). Aryl 
Schiff’s bases of benzyldehyde N-mustard and 4'-p-aminophenyl 
thiazole showed significant  
 
 
activity against lymphoid leukemia in phase III clinical trial (Fig. 
1.6) (Modi, Sabnis, and Deliwala, 1970).  
 
Recently, various synthetic and natural product based aryl Schiff’s 
bases were found to have antioxidant/radical scavenging activities 
with consequent protection from oxidative damage in many models 
of human diseases, including various types of cancers (Malik et al., 
2018). Antioxidants have been added as health promoters to diets, 
cosmetic products, and pharmaceutical preparations. Some 
antioxidants also have been tested in various in vivo clinical trials 
with undesirable results (Khurana et al., 2018).  
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with undesirable results (Khurana et al., 2018). For instance, “The 
Alpha-Tocopherol Beta-Carotene Cancer Prevention Study” 
(ATBC), conducted on heavy smokers and alcohol drinkers, 
showed that beta-carotene supplementation resulted in 16% more 
lung cancers, and 14% more deaths (Albanes et al., 1996). 
Similarly, the “Carotenoid and Retinol Efficacy Trial” (CARET), 
showed a 28% increase in lung cancer rates in individuals who 
were given beta-carotene as suppliment. Many more intervention 
studies of antioxidant molecules have been carried out either with 
no results or negative outcomes.  
 
 
 
 
 
 
More importantly, some of them have indicated that high doses of 
an antioxidant such as vitamin E may even raise the overall 
mortality risks (Sesso et al., 2008; Gerss and Köpcke, 2009).  
 
The pharmacokinetics properties (absorption, distribution, and 
elimination) of these antioxidants are possible reasons for the 
failure of these antioxidants in the reported in vivo studies. 
Additionally, in vitro antioxidants may lose such a property in vivo 
if the functional group in an antioxidant molecule is shielded by 
proteins or modified. These events make antioxidants behave 
differently in a chemical or biological environment.  
 
 
 
(1) (4) 
Fig. 1.6: Structures of potential anticancer aryl Schiff’s base. Anti-leukemic aryl Schiff’s bases of benzyldehyde N-mustard 
and 4'-p-aminophenyl thiazole has been evaluated in phase III clinical trial (Modi, Sabnis, and Deliwala, 1970).  compound (4) has 
been evaluated in oxidative stress cell models (Qurat-ul-Ain et al., 2017). 
 
 
Many synthetic and natural radical scavengers/antioxidants can be 
modified by methylation in the intestinal wall, which results in the 
loss of their antioxidant properties. As a result, only a fraction of 
antioxidant molecule, although somewhat bio-available, reaches 
its target site. For example, RRR alpha-tocopherol that is a well-
known natural antioxidant, that due to its ability to bind with 
tocopherol associated proteins (TAP), is slowly eliminated and 
thus its presence in the body is significant. Instead, most of the 
phenolic antioxidants, and for instance, other tocopherols, are 
taken up in minor amounts, and are extensively eliminated by the 
drug metabolizing enzymes. The phenolic compounds may lose 
their antioxidant properties either by binding with the proteins that 
prevents their interaction with reactive oxygen species (ROS) or 
by alteration of their antioxidant groups or by rapid metabolism, 
after absorption (Espinosa and Esposito, 2014). This does not 
mean that molecules that have lost their antioxidant capacity due 
to modification of the antioxidant group, or their shielding by 
proteins in a cellular environment, are biologically inactive 
because such molecules can exert their function as ligands of 
receptors or enzymes (Heim, Tagliaferro, and Bobilya, 2013; 
Qurat-ul-Ain, Choudhary, and Scharffetter-Kochanek, 2018). 
 
 
 
 
 
 
Moreover, natural or synthetic antioxidants may possess several 
non-antioxidant functions that may add to or substitute their 
native antioxidant properties. In conclusion, both a naturally 
occurring free radical scavenger or a compound that has been 
characterized as antioxidant due to having free radical 
scavenging functionalities, in some situation may not exert an 
antioxidant function in some situations. The well-known 
antioxidant alpha-tocopherol, and the mild antioxidants retinol 
or estrogens may be listed as examples. All these natural 
antioxidants are protected from oxidation or enzymatic 
modifications by associating with certain proteins such as the 
cellular “tocopherol associated protein” (TAP), which prevent 
their attack by oxygen radicals (Azzi, 2009; Azzi, Meydani, 
Meydani, and Zingg, 2016). Therefore, free radical molecules 
that have shown their activity in a chemical environment may 
have their functions either modified or blocked in biological 
systems like human body. However, these antioxidant 
molecules, and their metabolites with masked antioxidant 
activities might display more important activities than free 
radical scavenging activitiy in physiological system (Choudhary 
and Kochanek, 2017). It is, therefore, important to explore other 
useful biological targets of antioxidants/free radical scavengers 
along with their radical scavenging properties. 
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4. Conclusion 
 
Free radicals produced from different sources are generally known 
to induced oxidative stress and detrimental to human health. A large 
number of studies demonstrates that in fact free radicals target all 
biological macromolecules and contribute to initiation and 
progression of several pathologies, including various types of 
cancers. 
 
A number of antioxidants class have been identified that able to 
counteract oxidative stress in in vitro system via their free radical 
scavenging activity and  considered to be mitigate its effects on 
individuals’ health, gained enormous attention from the biomedical 
research, however some of them when tested in clinical trials showed 
their negative results due to their metabolism and masking of their 
free radical functional groups therefore, it is  important to explore 
new classes of antioxidants compounds and their other useful 
biological targets of antioxidants/free radical scavengers along with 
their radical scavenging properties that can be well useful to human 
health, particularly regarding cancer treatment. 
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